CreativeOne Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

CreativeOne Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,606	Closed	-$259K	–	1273
2026 Q1	$259K	Sell	8,606 -51,928	-86%	-$1.67M	0.01%	1033
2025 Q4	$1.89M	Buy	+60,534	New	+$1.49M	0.05%	347
2025 Q1	–	Sell	-39,413	Closed	-$869K	–	1139
2024 Q4	$869K	Buy	+39,413	New	+$717K	0.03%	517

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

CreativeOne Wealth's TEVA Position: Q2 2026 in Review

CreativeOne Wealth sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 8,606 shares — an estimated $259K sold.

CreativeOne Wealth first reported a position in TEVA in Q4 2024 and held it in 3 quarters. The position peaked at $1.89M in Q4 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

CreativeOne Wealth reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
CreativeOne Wealth sold 8,606 Teva Pharmaceuticals shares in Q2 2026, an estimated $259K.
CreativeOne Wealth first reported a position in Teva Pharmaceuticals in Q4 2024 and held it in 3 quarters.
CreativeOne Wealth's Teva Pharmaceuticals position peaked at $1.89M in Q4 2025.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.